Suppr超能文献

通过切伦科夫成像与闪烁剂量测定法联合进行全乳放疗的视觉剂量监测

Visual Dose Monitoring for Whole Breast Radiation Therapy Treatments via Combined Cherenkov Imaging and Scintillation Dosimetry.

作者信息

Decker Savannah M, Bruza Petr, Zhang Rongxiao, Pogue Brian W, Gladstone David J, Jarvis Lesley A

机构信息

Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire.

Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire.

出版信息

Int J Radiat Oncol Biol Phys. 2025 Feb 1;121(2):365-374. doi: 10.1016/j.ijrobp.2024.08.033. Epub 2024 Sep 7.

Abstract

PURPOSE

This study investigates scintillation dosimetry coupled with Cherenkov imaging for in vivo dose monitoring during whole breast radiation therapy (WBRT). Given recent observations of excess dose to the contralateral breast (CB), in vivo dosimetry (IVD) could help ensure accurate dose delivery and decrease risks of secondary cancer. This work presents a rapid, streamlined alternative to traditional IVD, providing direct visualization of measurement location relative to the treatment field on the patient.

METHODS AND MATERIALS

Ten WBRT patients consented under an institutional review board-approved protocol were monitored with scintillation dosimetry and always-on Cherenkov imaging, on both their treated and CB for 1 to 3 fractions. Scintillator dosimeters, small plastic discs 1 mm thick and 15 mm in diameter, were calibrated against optically stimulated luminescent dosimeters (OSLDs) to generate an integral output-to-dose conversion, where integral output is measured in postprocessing through a custom fitting algorithm. The discs have been extensively characterized in a previous study for various treatment conditions including beam energy and treatment geometry.

RESULTS

A total of 44 dosimetry measurements were evaluated, including 22 treated breast and 22 CB measurements. After integral output-to-dose calibration, in vivo scintillator dosimeters exhibited high linearity (R = 0.99) with paired OSLD readings across all patients. The difference between scintillation and OSLD dose measurements averaged 2.8% of the prescribed dose, or an absolute dose difference of approximately 7 cGy.

CONCLUSIONS

Integration of scintillation dosimetry with Cherenkov imaging offers an accurate, rapid alternative for in vivo dose verification in WBRT, circumventing the limitations of conventional point dosimeters. The additional benefit of visualizing measurement locations relative to the treatment field provides users an enhanced understanding of results and allows for detection of high dose gradients. Future work will explore the applicability of this technique across a broader range of radiation therapy treatments, aiming to streamline IVD practices.

摘要

目的

本研究调查了在全乳放疗(WBRT)期间,将闪烁剂量测定法与切伦科夫成像相结合用于体内剂量监测的情况。鉴于最近观察到对侧乳腺(CB)存在过量剂量,体内剂量测定(IVD)有助于确保准确的剂量输送并降低继发癌症的风险。这项工作提出了一种快速、简化的传统IVD替代方法,可直接可视化相对于患者治疗野的测量位置。

方法和材料

根据机构审查委员会批准的方案,对10名接受WBRT的患者进行了闪烁剂量测定和持续的切伦科夫成像监测,对其治疗侧乳腺和对侧乳腺进行了1至3次分次测量。闪烁体剂量计为1毫米厚、15毫米直径的小塑料圆盘,通过与光激励发光剂量计(OSLD)校准来生成积分输出与剂量的转换关系,其中积分输出通过定制拟合算法在后期处理中进行测量。这些圆盘在先前的一项研究中已针对包括束能量和治疗几何形状在内的各种治疗条件进行了广泛表征。

结果

共评估了44次剂量测定测量,包括22次治疗侧乳腺测量和22次对侧乳腺测量。在进行积分输出与剂量校准后,体内闪烁体剂量计与所有患者的配对OSLD读数呈现出高度线性(R = 0.99)。闪烁剂量测量与OSLD剂量测量之间的差异平均为规定剂量的2.8%,或绝对剂量差异约为7 cGy。

结论

将闪烁剂量测定法与切伦科夫成像相结合,为WBRT中的体内剂量验证提供了一种准确、快速的替代方法,规避了传统点剂量计的局限性。相对于治疗野可视化测量位置的额外好处是,能让使用者更好地理解结果,并检测到高剂量梯度。未来的工作将探索该技术在更广泛的放射治疗中的适用性,旨在简化IVD实践。

相似文献

本文引用的文献

2
Clinical implementation of the first Cherenkov imaging system in a community-based hospital.基于社区的医院中首个切伦科夫成像系统的临床应用。
Tech Innov Patient Support Radiat Oncol. 2022 Sep 9;24:1-5. doi: 10.1016/j.tipsro.2022.08.011. eCollection 2022 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验